IDH1 and brain neoplasm: By contrast, another recent report has shown that mutant IDH1 proteins exhibit a gain-of-function phenotype by generating R-2-hydroxyglutarate (2HG), a toxic metabolite associated with an increased risk of malignant brain tumours in patients with inherited errors of 2HG metabolism [62].